Title |
Repression of human activation induced cytidine deaminase by miR-93 and miR-155
|
---|---|
Published in |
BMC Cancer, August 2011
|
DOI | 10.1186/1471-2407-11-347 |
Pubmed ID | |
Authors |
Glen M Borchert, Nathaniel W Holton, Erik D Larson |
Abstract |
Activation Induced cytidine Deaminase (AID) targets the immunoglobulin genes of activated B cells, where it converts cytidine to uracil to induce mutagenesis and recombination. While essential for immunoglobulin gene diversification, AID misregulation can result in genomic instability and oncogenic transformation. This is classically illustrated in Burkitt's lymphoma, which is characterized by AID-induced mutation and reciprocal translocation of the c-MYC oncogene with the IgH loci. Originally thought to be B cell-specific, AID now appears to be misexpressed in several epithelial cancers, raising the specter that AID may also participate in non-B cell carcinogenesis. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Australia | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 4% |
United Kingdom | 1 | 1% |
China | 1 | 1% |
Canada | 1 | 1% |
Unknown | 69 | 92% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 19 | 25% |
Researcher | 9 | 12% |
Student > Master | 8 | 11% |
Student > Doctoral Student | 6 | 8% |
Student > Bachelor | 6 | 8% |
Other | 11 | 15% |
Unknown | 16 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 26 | 35% |
Biochemistry, Genetics and Molecular Biology | 16 | 21% |
Medicine and Dentistry | 7 | 9% |
Immunology and Microbiology | 4 | 5% |
Engineering | 2 | 3% |
Other | 2 | 3% |
Unknown | 18 | 24% |